After spending 3 years in the US as a postdoctoral fellow at the National Institutes of Health (NIH), 32-year-old Emeline Ragonnaud has now moved to Denmark and joined InProTher. But apart from being a story…

InProTher is pleased to announce the appointment of Kim Arvid Nielsen, MD, EMBA, as Chief Executive Officer. Coming from a similar position in the Danish biotech company Cytovac, he has highly relevant experience in working…

“I was in our sailboat with my dad. I think I was 8 or 9 years old. I asked him if anything exciting happened recently. He said he had discovered a new hormone which was…

InProTher is pleased to welcome Christian O. Thirion, Ph.D., who has joined the Board of Directors in February 2020. Christian is the founder and CEO of SIRION Biotech GmbH, a company that InProTher recently entered…

InProTher can proudly welcome John Haurum, M.D., Ph.D. as a strategic advisor. John Haurum is a Non-executive Director in various European biotech companies, i.e. Synklino, Neophore, and Synact. From 2012 – 2018, Haurum was the…

MUNICH & COPENHAGEN, February 4, 2020— SIRION Biotech GmbH (“SIRION”), a world leader in viral vector-based gene delivery technologies for gene and cell therapy, and InProTher Aps (“InProTher”), a Danish start up supported by Novo…

After joining InProTher as the CEO in June 2019, Mathias Kroll has now decided to step down. It is not a goodbye, though, as he will continue as a strong player on the Advisory Board….

Please meet us at the 2020 Biotech Showcase in San Francisco, where Inprother CBO, Dr. Mathias Kroll will be presenting Inprother.   The presentation will take place at 10.00AM January 4th 2020 at:   Hilton San Francisco Union Square…

Steven Glazer has many years of international experience in healthcare and biotechnology. He has held a number of senior positions within pharmaceutical and bioengineering companies in Europe and the US, including Novo Nordisk, Zealand Pharma,…